Education
About Us
Working with TipRanks
Follow Us
Essex Bio-Technology (HK:1061)
:1061
RESEARCH TOOLSreports
1061 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.15 - HK$5.43
Previous CloseN/A
Volume76.00K
Average Volume (3M)2.02M
Market Cap
HK$2.89B
Enterprise ValueHK$2.36B
Total Cash (Recent Filing)HK$560.74M
Total Debt (Recent Filing)HK$187.04M
Price to Earnings (P/E)9.4
Beta0.46
Next Earnings
Aug 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2025Dividend Yield2.36%
Share Statistics
EPS (TTM)0.54
Shares Outstanding567,006,000
10 Day Avg. Volume2,685,910
30 Day Avg. Volume2,016,572
Financial Highlights & Ratios
PEG Ratio-0.31
Price to Book (P/B)1.39
Price to Sales (P/S)0.00
P/FCF Ratio24.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Essex Bio-Technology News
PremiumCompany Announcements
Essex Bio-Technology AGM Resolutions Successfully Passed
PremiumCompany Announcements
Essex Bio-Technology Announces AGM and Key Resolutions
PremiumCompany Announcements
Essex Bio-Technology Proposes Amendments to Articles of Association
PremiumCompany Announcements
Essex Bio-Technology Reports Strong Profit Growth Despite Turnover Decline
PremiumCompany Announcements
Essex Bio-Technology Declares Final Dividend for 2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.59%
Mutual Funds
― Other Institutional Investors
98.30% Public Companies and
Individual Investors
1061 FAQ
What was Essex Bio-Technology ’s price range in the past 12 months?
Essex Bio-Technology lowest stock price was HK$2.15 and its highest was HK$5.43 in the past 12 months.
What is Essex Bio-Technology ’s market cap?
Essex Bio-Technology ’s market cap is HK$2.89B.
When is Essex Bio-Technology ’s upcoming earnings report date?
Essex Bio-Technology ’s upcoming earnings report date is Aug 26, 2025 which is in 72 days.
How were Essex Bio-Technology ’s earnings last quarter?
Essex Bio-Technology released its earnings results on Mar 26, 2025. The company reported HK$0.264 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.264.
Is Essex Bio-Technology overvalued?
According to Wall Street analysts Essex Bio-Technology ’s price is currently Overvalued.
Does Essex Bio-Technology pay dividends?
Essex Bio-Technology pays a Annually dividend of HK$0.118 which represents an annual dividend yield of 2.36%. See more information on Essex Bio-Technology dividends here
What is Essex Bio-Technology ’s EPS estimate?
Essex Bio-Technology ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Essex Bio-Technology have?
Essex Bio-Technology has 567,006,000 shares outstanding.
What happened to Essex Bio-Technology ’s price movement after its last earnings report?
Essex Bio-Technology reported an EPS of HK$0.264 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.717%.
Which hedge fund is a major shareholder of Essex Bio-Technology ?
Currently, no hedge funds are holding shares in HK:1061
Essex Bio-Technology Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
107.67%
12-Months-Change
Fundamentals
Return on Equity
15.18%
Trailing 12-Months
Asset Growth
5.50%
Trailing 12-Months
Company Description
Essex Bio-Technology
Essex Bio-Technology (1061) is a biopharmaceutical company specializing in the research, development, and commercialization of therapeutics for the treatment of eye diseases and wound healing. With a focus on regenerative medicine, the company leverages its expertise in bioactive proteins and peptides to offer innovative solutions that address significant unmet medical needs. Essex Bio-Technology operates primarily in the ophthalmology and dermatology sectors, providing a range of products that enhance tissue repair and regeneration.
Technical Analysis
China Shineway Pharmaceutical Group Limited
―
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
―
Consun Pharmaceutical Group Ltd.
―
China Traditional Chinese Medicine Holdings Co
―
Sihuan Pharmaceutical Holdings Group
―